APO-MOMETASONE — Canadian drug shortage status

Shortage reports for APO-MOMETASONE filed with Health Canada's drug shortage register, as tracked by Nexara. Each row is one reported presentation or strength.

Sourcing during a shortage

When a Canadian product is in shortage, Health Canada may permit exceptional importation of a foreign-authorized equivalent, and practitioners may apply through the Special Access Programme. Read how named-patient and foreign-pack supply works in Canada.

All Canadian drug shortages